K R Servelhere1, R F Casseb2, F D de Lima1, T J R Rezende1, L P Ramalho1, M C França3. 1. From the School of Medical Sciences (K.R.S., F.D.d.L. T.J.R.R., L.P.R., M.C.F.), University of Campinas, Campinas, Brazil. 2. Seaman Family MR Research Center (R.F.C.), University of Calgary, Calgary, Alberta, Canada. 3. From the School of Medical Sciences (K.R.S., F.D.d.L. T.J.R.R., L.P.R., M.C.F.), University of Campinas, Campinas, Brazil mcfrancajr@uol.com.br.
Abstract
BACKGROUND AND PURPOSE: Spinal cord damage is a hallmark of hereditary spastic paraplegias, but it is still not clear whether specific subtypes of the disease have distinctive patterns of spinal cord gray (GM) and white (WM) matter involvement. We compared cervical cross-sectional GM and WM areas in patients with distinct hereditary spastic paraplegia subtypes. We also assessed whether these metrics correlated with clinical parameters. MATERIALS AND METHODS: We analyzed 37 patients (17 men; mean age, 47.3 [SD, 16.5] years) and 21 healthy controls (7 men; mean age, 42.3 [SD, 13.2] years). There were 7 patients with spastic paraplegia type 3A (SPG3A), 12 with SPG4, 10 with SPG7, and 8 with SPG11. Image acquisition was performed on a 3T MR imaging scanner, and T2*-weighted 2D images were assessed by the Spinal Cord Toolbox. Statistical analyses were performed in SPSS using nonparametric tests and false discovery rate-corrected P values < .05. RESULTS: The mean disease duration for the hereditary spastic paraplegia group was 22.4 [SD, 13.8] years and the mean Spastic Paraplegia Rating Scale score was 22.8 [SD, 11.0]. We failed to identify spinal cord atrophy in SPG3A and SPG7. In contrast, we found abnormalities in patients with SPG4 and SPG11. Both subtypes had spinal cord GM and WM atrophy. SPG4 showed a strong inverse correlation between GM area and disease duration (ρ = -0.903, P < .001). CONCLUSIONS: Cervical spinal cord atrophy is found in some but not all hereditary spastic paraplegia subtypes. Spinal cord damage in SPG4 and 11 involves both GM and WM.
BACKGROUND AND PURPOSE: Spinal cord damage is a hallmark of hereditary spastic paraplegias, but it is still not clear whether specific subtypes of the disease have distinctive patterns of spinal cord gray (GM) and white (WM) matter involvement. We compared cervical cross-sectional GM and WM areas in patients with distinct hereditary spastic paraplegia subtypes. We also assessed whether these metrics correlated with clinical parameters. MATERIALS AND METHODS: We analyzed 37 patients (17 men; mean age, 47.3 [SD, 16.5] years) and 21 healthy controls (7 men; mean age, 42.3 [SD, 13.2] years). There were 7 patients with spastic paraplegia type 3A (SPG3A), 12 with SPG4, 10 with SPG7, and 8 with SPG11. Image acquisition was performed on a 3T MR imaging scanner, and T2*-weighted 2D images were assessed by the Spinal Cord Toolbox. Statistical analyses were performed in SPSS using nonparametric tests and false discovery rate-corrected P values < .05. RESULTS: The mean disease duration for the hereditary spastic paraplegia group was 22.4 [SD, 13.8] years and the mean Spastic Paraplegia Rating Scale score was 22.8 [SD, 11.0]. We failed to identify spinal cord atrophy in SPG3A and SPG7. In contrast, we found abnormalities in patients with SPG4 and SPG11. Both subtypes had spinal cord GM and WM atrophy. SPG4 showed a strong inverse correlation between GM area and disease duration (ρ = -0.903, P < .001). CONCLUSIONS: Cervical spinal cord atrophy is found in some but not all hereditary spastic paraplegia subtypes. Spinal cord damage in SPG4 and 11 involves both GM and WM.
Authors: Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry Journal: J Magn Reson Imaging Date: 2014-12-08 Impact factor: 4.813
Authors: Rebecca S Samson; Simon Lévy; Torben Schneider; Alex K Smith; Seth A Smith; Julien Cohen-Adad; Claudia A M Gandini Wheeler-Kingshott Journal: PLoS One Date: 2016-05-12 Impact factor: 3.240
Authors: Ferran Prados; John Ashburner; Claudia Blaiotta; Tom Brosch; Julio Carballido-Gamio; Manuel Jorge Cardoso; Benjamin N Conrad; Esha Datta; Gergely Dávid; Benjamin De Leener; Sara M Dupont; Patrick Freund; Claudia A M Gandini Wheeler-Kingshott; Francesco Grussu; Roland Henry; Bennett A Landman; Emil Ljungberg; Bailey Lyttle; Sebastien Ourselin; Nico Papinutto; Salvatore Saporito; Regina Schlaeger; Seth A Smith; Paul Summers; Roger Tam; Marios C Yiannakas; Alyssa Zhu; Julien Cohen-Adad Journal: Neuroimage Date: 2017-03-07 Impact factor: 6.556
Authors: Francisco Grandas; Manuel Desco; Francisco J Navas-Sánchez; Luis Marcos-Vidal; Daniel Martín de Blas; Alberto Fernández-Pena; Yasser Alemán-Gómez; Juan A Guzmán-de-Villoria; Julia Romero; Irene Catalina; Laura Lillo; José L Muñoz-Blanco; Andrés Ordoñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanna Carmona Journal: J Neurol Date: 2022-01-09 Impact factor: 4.849
Authors: Christoph Kessler; Lina Maria Serna-Higuita; Carlo Wilke; Tim W Rattay; Holger Hengel; Jennifer Reichbauer; Elke Stransky; Alejandra Leyva-Gutiérrez; David Mengel; Matthis Synofzik; Ludger Schöls; Peter Martus; Rebecca Schüle Journal: Ann Clin Transl Neurol Date: 2022-02-16 Impact factor: 4.511